## FROG: JFrog Ltd. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -2.6% below STRENGTH zone (3.0-6.0%); PEG 1.37 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($54.34)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.35M) |
| Sells | 20 ($16.90M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 28.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 7.7% (+2.5%)
- Optimus Prime Fund M: 4.0% (0.0%)
- Whale Rock Capital M: 2.5% (+69.7%)
- Times Square Capital: 2.5% (-14.9%)
- Wasatch Advisors LP: 2.3% (+6.0%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-4.1% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $17M sold (20 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.37 suggests fair value with growth premium. Forward P/E 67.8x stretched relative to 11% growth. Balance sheet: strong liquidity (2.2x), low leverage (D/E 0.47). Insider selling cluster ($16.9M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.1B |
| Beta | 1.10 |
| 52W Range | $27.00 - $70.43 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.37 |
| Forward P/E | 67.8 |
| Current P/E | 75.4 |
| YoY Growth | 11.2% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 1.5% to -2.6% (-4.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.6pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 58.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.58% (CS: 19) | Weak |
| RSI_14 | 57.7 | Neutral |
| MACD Histogram | -0.12 | Bearish |
| vs SMA20 | 1.032x | Above |
| vs SMA50 | 1.146x | Above |
| vs SMA200 | 1.388x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $59.72
- **Stop Loss:** $54.34 (9.0% risk)
- **Target:** $65.10 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 223
- **Position Value:** $13,317.56
- **Portfolio %:** 13.32%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

### Earnings

**Next:** 2026-02-12 (Est: $0.19)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.16 | $0.22 | +34.4% |
| 2025Q2 | $0.16 | $0.18 | +10.1% |
| 2025Q1 | $0.16 | $0.20 | +21.5% |
| 2024Q4 | $0.14 | $0.19 | +36.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*